SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION AS AN OPTION FOR MANAGING THE LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE POST HOC ANALYSIS OF LIBERTY-UC AND LIBERTY-CD STUDY.

Details

Language :

English

ISSN :

00165085

Volume :

166

Issue :

3

Database :

Supplemental Index

Journal :

Gastroenterology (00165085)

Publication Type :

Academic Journal

Accession number :

174579399

Full Text :

https://doi.org/10.1053/j.gastro.2023.11.054